In an effort to nurture the budding medical devices sector within the nation, the central government has initiated a scheme titled ‘Enhancement of Medical Device Industry,’ earmarking an initial fund of Rs. 500 crore across three years from 2024-25 to […]
A Move towards Autonomy Read More »
The United Kingdom and the Republic of Korea have joined forces in a fresh alliance that seeks to accelerate, optimize, and enhance the productivity of clinical trials. The objective is to establish quicker, more efficient, and fairer pathways to safe
Haemonetics Corporation, a leading player in medical technology specializing in breakthrough healthcare solutions for enhanced patient outcomes, has disclosed a definitive pact to divest its whole blood assets to GVS, S.p.A (GVS). GVS stands as a prominent manufacturer of filtration
Haemonetics Offloads Whole Blood Resources to GVS for $67.1 Million Read More »
To fortify its defenses against a potential H5 influenza pandemic, the UK Government has secured a contract for upwards of five million doses of the H5 influenza vaccine. This strategic move aims to bolster the nation’s resilience and preparedness. The
In response to the tragic deaths of four expectant mothers who were given below-standard Ringer’s lactate solution—an intravenous fluid typically administered to restore hydration and electrolyte equilibrium—the Karnataka government has decided to suspend Dr. Umesh S., the state’s drugs controller,
The updated guidelines released on May 1 by the National Commission for Indian System of Medicine (NCISM) to evaluate and govern the minimum standards and criteria (MSR) applicable to self-supporting Ayurveda educational institutions and their affiliated hospitals will not entirely
Revised Regulations Won’t Impact Current Ayurveda Colleges: NCISM Head Read More »
The Health and Family Welfare Department of Karnataka has urged the Drugs Controller General of India (DCGI) to swiftly investigate and address the issue of substandard Ringer’s lactate IV infusion fluid supplied by Paschim Banga Pharmaceutical, a West Bengal company.
Karnataka Health Department Requests DCGI to Probe and Act Against Paschim Banga Pharma Read More »
Over the past five years, the Pharmaceuticals & Medical Devices Bureau of India (PMBI), overseen by the Department of Pharmaceuticals (DoP), has prohibited six pharmaceutical suppliers from providing medications to Jan Aushadhi Kendras (JAKs) due to their failure to adhere
Six Pharmaceutical Suppliers Blacklisted by PMBI Over Quality Concerns in Recent Years Read More »
Supported by Kiran Mazumdar-Shaw, Dr. Ranjan Pai, and various angel investors, UE LifeSciences, a leader in women’s healthcare innovation, is preparing to roll out its RaKSA program aimed at identifying breast, cervical, and oral cancers in primary health centres (PHCs)
HealthCare Global Enterprises (HCG) has teamed up with Accenture to propel advancements in cancer research and treatment by harnessing the power of cutting-edge artificial intelligence (AI), including generative AI and deep learning for multi-dimensional, patient-specific data analysis. This alliance merges